Agoracom Blog Home

Author Archive

FEATURE: betterU Education $BTRU.ca The Only Education Marketplace In #India Serving 1.3 Billion Potential Customers #edtech $ARCL $BPI $FC.ca

Posted by AGORACOM-JC at 12:33 PM on Tuesday, May 8th, 2018

CONNECTING GLOBAL EDUCATION WITH THE INDIAN MARKETPLACE

HIGHLIGHTS

  • The ONLY Global Education Marketplace Serving India
  • Launched full-scale mass marketing print campaign through Hindustan Times, Hindustan and The Mint last week across India (Check it out)
  • Signed Definitive Agreement With Swift e-Learning Services to Launch e-Template Marketplace to Support India’s Content Development Requirements
  • Launching Education Blockchain Ecosystem Project Read More
  • Executes on Definitive Agreement With One of India’s Largest Media Conglomerates (HT Overseas Pte. Ltd.) for a $10 Million Media Investment (completed first tranche of $1.25M) Read More
  • betterU Partners With Adobe to Deliver Leading Digital Experience Programs in India
  • Executed MOU with the Telecom Sector Skill Council to jointly support both organizations’ efforts towards the skilling of millions of professionals across India’s Telecom sector Read More
  • Capitalizing On Mobile Payments Structure Others Unable To Provide
  • Unique Ability To Collect From 200 Different Payment Methods in India
  • BetterU Receives 20 – 50% Of All Revenues Generated

New Age Metals $NAM.ca Announces 4,626,250 PdEq Ounces, With 2,713,933 Ounces in Inferred NI 43-101 Update River Valley Platinum Group Metal Deposit, Sudbury $WG.ca $XTM.ca $WM.ca $PDL.ca $GLEN

Posted by AGORACOM-JC at 10:10 AM on Tuesday, May 8th, 2018

New age large

  • River Valley is the largest undeveloped primary PGM resource in Canada, the March 2018 NI 43-101 has updated the 2012 resource. The River Valley PGM Project has excellent infrastructure and is within 100 kilometers of the Sudbury Metallurgical Complex. The project is 100% owned by New Age Metals.
  • 4,626,250 PdEq ounces, with 2,713,933 ounces in Inferred at a 0.4 g/t cut-off.
  • The company objective of increasing the resource beyond 1Moz in the northern portion was achieved.
  • Footwall PGM mineralization, “The Pine Zone/T3”, a new discovery and additional source of PGMs at the River Valley Project (RVP), was included in the new resource model.
  • The River Valley Extension mineralization in the south end of the deposit was added to the NI 43-101 Resource Calculation
  • The 43-101 is filed on Sedar at www.sedar.com or on the NAM website at 2018 NI 43-101.
  • Lithium Division: A minimum of $600,000 will be expended in 2018 on the companies Lithium division by New Age Metals option/joint venture partner Azincourt Energy Corp. (TSX.V: AAZ) (news release May 2nd, 2018) The 2018 budget will allow for 2 out of the 3 drill ready projects to be drilled. New Age Metals technical team is the field manager (press release dated Jan 15th, 2018).

May 8th 2018 / Rockport, Canada – New Age Metals Inc.(NAM) (TSX.V: NAM; OTCQB: NMTLF; FSE: P7J.F) The company is very pleased to announce that the NI43-101 compliant Measured and Indicated mineral resource calculation at a cut-off grade of 0.4 g.t PdEq is complete and has been posted on Sedar and the company website. The River Valley PGM Project is located 100 km from the world-class Sudbury Ni-Cu-PGM Mining Camp and has excellent infrastructure. The project is 100% owned by New Age Metals (NAM).

If you have not done so already, we encourage you to sign up on our website (www.newagemetals.com) to receive our updated news or click here.

New NI 43-101 Compliant Resource Estimation

WSP Canada, under the supervision of Todd McCracken, P. Geo (Manager-Mining at WSP Canada) has completed the new NI 43-101 compliant resource estimation of the River Valley PGM Deposit in the Sudbury Mining District of Ontario, Canada. The new resource estimation has incorporated all the past data, geophysics, new drilling since 2015 and the River Valley Extension (RVE), including the additional drilling in the new footwall discoveries Pine Zone and T3.

The results of the new resource estimation are tabulated in Table 1 below (0.4 PdEq cut-off).

Class Tonnes

‘,000

Pd (g/t) Pt (g/t) Rh (g/t) Au (g/t) Cu (%) Ni (%) Co (%) PdEq (g/t)
Total Measured 62,877.5 0.49 0.19 0.02 0.03 0.05 0.01 0.002 0.99
Total Indicated 97,855.2 0.40 0.16 0.02 0.03 0.05 0.01 0.002 0.83
Total Meas +Ind 160,732.7 0.44 0.17 0.02 0.03 0.05 0.01 0.002 0.90
Inferred 127,662.0 0.27 0.12 0.01 0.02 0.05 0.02 0.002 0.66

 

Class PGM + Au (oz) PdEq (oz) PtEq (oz) AuEq (oz)
Total Measured 1,440,248 1,999,575 1,999,575 1,136,930
Total Indicated 1,856,925 2,626,675 2,626,675 1,463,793
Total Meas +Ind 3,297,173 4,626,250 4,626,250 2,600,724
Inferred 1,578,367 2,713,933 2,713,933 1,323,809

 

Table 1: River Valley 2018 Resource Calculation (WSP Canada, Todd McCracken, P.Geo)

 

Notes:

  1. 1.CIM definition standards were followed for the resource calculation.
  2. 2.The 2018 resource models used Ordinary Krig grade estimation within a three-dimensional block model with mineralized zones defined by wireframed solids.
  3. 3.A base cut-off grade of 0.4 % g/t PdEq was used for reporting resources.
  4. 4.Palladium Equivalent (PdEq) calculated using (US$): $1,000/oz Pd, $1,000/oz Pt, $1,350/oz Au, $1750/oz Rh, $3.20/lb Cu, $5.50/lb Ni, $36/lb Co.
  5. 5.Numbers may not add exactly due to rounding.
  6. 6.Mineral Resources that are not mineral reserves do not have economic viability
  7. 7.The quantity and grade of reported inferred resources in this estimation are uncertain in nature and there has been insufficient exploration to define these inferred resources as an indicated or measured mineral resource and it is uncertain if further exploration will result in upgrading them to an indicated or measured mineral resource category.

To date, approximately 45 million dollars has been expended by NAM and previous partners on the projects. The River Valley mineralized contact extends throughout the 16 kilometers of the project as well as the additional possibility of other footwall mineralization zones. To date footwall PGM mineralization has been identified the Pine and T3 Zone.


Click Image To View Full Size

Figure 1: River Valley Geology and Zone Map, 2018

Zone Tonnes Pd (g/t) Pt
(g/t)
Au
(g/t)
Ni
(%)
Cu
(%)
Co
(%)
Rh (g/t) PdEq (g/t)
Measured Resources
Dana 32,631,150 0.52 0.20 0.04 0.01 0.06 0.002 0.02 1.05
Pine 2,568,000 0.55 0.20 0.03 0.02 0.06 0.004 0.01 1.11
Dana S 9,433,730 0.58 0.21 0.04 0.01 0.05 0.003 0.02 1.10
Lismer 18,244,630 0.38 0.16 0.03 0.01 0.04 0.002 0.01 0.80
Lismer Ext
Varley
Razor
Banshee
Azen
River Valley Ext
TOTAL 62,877,510 0.49 0.19 0.03 0.01 0.05 0.002 0.02 0.99
Indicated Resources
Dana 2,175,700 0.53 0.22 0.02 0.02 0.06 0.0003 0.01 1.00
Pine 271,600 0.49 0.21 0.02 0.01 0.07 0.001 0.01 0.97
Dana S 13,573,600 0.51 0.18 0.03 0.01 0.04 0.003 0.02 0.97
Lismer 33,356,300 0.35 0.14 0.03 0.02 0.05 0.002 0.01 0.77
Lismer Ext 19,836,300 0.46 0.19 0.03 0.01 0.05 0.002 0.02 0.93
Varley 28,632,100 0.37 0.14 0.02 0.01 0.05 0.002 0.01 0.76
Razor
Banshee 9,600 0.26 0.16 0.03 0.00 0.03 0.01 0.55
Azen
River Valley Ext
TOTAL 97,855,200 0.40 0.16 0.03 0.01 0.05 0.002 0.02 0.83
(table continues on next page)
Measured & Indicated Resources
Dana 34,806,850 0.52 0.20 0.04 0.01 0.06 0.002 0.02 1.05
Pine 2,839,600 0.55 0.20 0.03 0.02 0.06 0.003 0.01 1.10
Dana S 23,007,330 0.54 0.19 0.03 0.01 0.04 0.003 0.02 1.02
Lismer 51,600,930 0.36 0.14 0.03 0.02 0.05 0.002 0.01 0.78
Lismer Ext 19,836,300 0.46 0.19 0.03 0.01 0.05 0.002 0.02 0.93
Varley 28,632,100 0.37 0.14 0.02 0.01 0.05 0.002 0.01 0.76
Razor
Banshee 9,600 0.26 0.16 0.03 0.00 0.03 0.01 0.55
Azen
River Valley Ext
TOTAL 160,732,710 0.44 0.17 0.03 0.01 0.05 0.002 0.02 0.90
Inferred Resources
Dana 272,000 0.56 0.21 0.00 0.01 0.05 0.02 0.94
Pine 51,000 0.37 0.21 0.00 0.00 0.04 0.00 0.66
Dana S
Lismer 2,453,000 0.22 0.10 0.02 0.01 0.04 0.002 0.01 0.54
Lismer Ext
Varley 125,000 0.20 0.11 0.03 0.02 0.05 0.002 0.01 0.58
Razor 42,744,000 0.26 0.11 0.02 0.03 0.04 0.001 0.01 0.63
Banshee 13,893,000 0.25 0.14 0.03 0.01 0.04 0.01 0.57
Azen 35,903,000 0.27 0.09 0.02 0.03 0.05 0.00 0.01 0.70
River Valley Ext 32,221,000 0.29 0.17 0.02 0.03 0.05 0.70
TOTAL 127,662,000 0.27 0.12 0.02 0.02 0.05 0.002 0.01 0.66

 

Table 2: River Valley Detailed Resource Summary (using 0.4 g/t PdEq Cutoff)

 


Click Image To View Full Size

Figure 2: Northern Portion of the River Valley PGM Deposit Showing Regions of Recent IP Geophysics and grade at a 0.4g/t cut-off. NOTE: Image only represents approximately 3.5 km of the 16 km of the overall strike length of the River Valley PGM deposit. Note: The Yellow Band represents the footwall potential area of the River Valley Deposit based on the results of the Pine Zone where footwall mineralization was noted to extend 150 meters eastward from the Pine Zone/ T3 main deposit. At present the only area that has confirmed footwall mineralization is in the Pine Zone (defined from 2015 to 2017 drilling). Geophysics and exploration are in progress to test other areas of the project.

River Valley 2018 Exploration & Development Objectives

  1. 1.Ground IP geophysics from T3 south to T9 (Completed);
  2. 2.Utilize the new resource estimation to establish further drill targets (Q1-Q3 2018);
  3. 3.Continue with drilling in the northern portion of the project (slated for Q3-Q4 2018 & Q1 2019);
  4. 4.Explore more target areas based on recommendations of the updated 43-101 and the 2018 geophysics (slated for Q3-Q4 2018 & Q1-Q2 2019);
  5. 5.Complete mineralogical studies (Complete), ongoing Metallurgical studies;
  6. 6.Continue to advance the River Valley PGM Project towards a Preliminary Economic Assessment (PEA) on the River Valley PGM Deposit; and
  7. 7.Our Corporate Mandate is to build a series of open pits (bulk mining) over the 16 kilometers of mineralization. We will mine, crush, and concentrate on site, then ship the concentrates to Sudbury. The objective of NAM before the March 2018 43-101 was to increase the resource in the northern portion (Pine Zone/Dana North/Dana South/Lismer North) to over 1Moz of PGMs. The new 43-101 accomplished this.

 


Click Image To View Full Size

 

Figure 3: Zone map of the River Valley PGM Deposit Note: The Yellow Band represents the footwall potential area of the River Valley Deposit based on the results of the Pine Zone where footwall mineralization was noted to extend 150 meters eastward from the Pine Zone/ T3 main deposit. At present the only area that has confirmed footwall mineralization is in the Pine Zone (defined from 2015 to 2017 drilling). Geophysics and exploration are in progress to test other areas of the deposit. Management’s specific focus is to outline a sufficient economic resource in the northern portion of the project, and then develop a series of open pits (bulk mining), crush, and concentrate on site, then ship the concentrates to Sudbury.

 

River Valley PGM Exploration Plan Going Forward

 

To date an approximate 140,659 meters (461,480 feet) in 628 drill holes have been conducted by the company as operator on the River Valley Project. Several independent NI 43-101 compliant resource calculations have previously been generated for the deposit through the exploration and development phases. In 2016, the company purchased 100% of Mustang Minerals’ southern portion of the River Valley contact (River Valley Extension, News Release – Oct 5th, 2016). This added 4 kilometers of mineralized strike length to the southern portion of the company’s main River Valley Project. The River Valley Deposit’s present resource, with approximately 4.6M PdEq ounces in Measured Plus Indicated mineral resources (0.4 g/t cut-off) and near-surface mineralization, covers over 16 kilometers of continuous strike length. The acquisition of the RVE adds an additional 4 kilometers for a total of 16 kilometers of strike. The March 2018 NI 43-101 report added a new inferred resource of PdEq (Oz) for a total of 729,658 ounces at a 0.4 g/t PdEq cut off on the River Valley Extension (RVE). The company continues to explore and enhance the River Valley PGM Deposit and is progressing towards the completion of a preliminary economic assessment, (PEA).

 

ABOUT NAM’S PGM DIVISION

 

NAM’s flagship project is its 100% owned River Valley PGM Project (NAM Website – River Valley Project) in the Sudbury Mining District of Northern Ontario (100 km east of Sudbury, Ontario). Presently the River Valley Project is North America’s largest undeveloped primary PGM deposit with Measured + Indicated resources of 160 million tones @ 0.44 g/t Palladium, 0.17 g/t Platinum, 0.03 g/t Gold, with a total metal grade of 0.64 g/t at a cut-off grade of 0.4 g/t equating to 3,297,173 ounces PGM plus Gold and 4,626,250 PdEq Ounces. This equates to 4,626,250 PdEq ounces M+I and 2,713,933 PdEq ounces in inferred (see March 21st, 2018 press release). Having completed a 2018 NI-43-101 resource update the company is finalizing its 2018 exploration programs which will include geophysics, and extensive drill programs, which are all working towards the completion of a Preliminary Economic Assessment (PEA). Our objective is to develop a series of open pits (bulk mining) over the 16 kilometers of mineralization, concentrate on site, and ship the concentrates to the long-established Sudbury Metallurgical Complex. Alaska: April 4th, 2018, NAM signed an agreement with one of Alaska’s top geological consulting companies. The companies stated objective is to acquire additional PGM and Rare Metal projects in Alaska. On April 18th, 2018, NAM announced the right to purchase 100% of the Genesis PGM Project, NAM’s first Alaskan PGM acquisition related to the April 4th agreement. The Genesis PGM Project is a road accessible, under explored, highly prospective, multi-prospect drill ready Pd-Pt-Ni-Cu property.

 

ABOUT NAM’S LITHIUM DIVISION

 

The Company has six pegmatite hosted Lithium Projects in the Winnipeg River Pegmatite Field, located in SE Manitoba. Three of the projects are drill ready. This Pegmatite Field hosts the world class Tanco Pegmatite that has been mined for Tantalum, Cesium and Spodumene (one of the primary Lithium ore minerals) in varying capacities, since 1969. NAM’s Lithium Projects are strategically situated in this prolific Pegmatite Field. Presently, NAM is the largest mineral claim holders for Lithium in the Winnipeg River Pegmatite Field. On January 15th 2018, NAM announced an agreement with Azincourt Energy Corporation (see Jan 15, 2018, Feb 22nd, 2018 and April 11th, 2018, May 2nd, 2018 Press Releases) whereby Azincourt will commit up to $4.1 million dollars in exploration, up to 3.25 million shares of Azincourt stock to NAM, up to $210,000 in cash, and a 2% net smelter royalty on all 6 projects. Exploration plans for 2018 are currently in progress, whereby a minimum of $600,000 will be expended this year. For complete details on the terms and conditions of the NAM/AAZ option joint venture please see the press release dated Jan 15th, 2018.

 

QUALIFIED PERSON

The contents contained herein that relate to Exploration Results or Mineral Resources is based on information compiled, reviewed or prepared by Carey Galeschuk, a consulting geoscientist for New Age Metals. Mr. Galeschuk is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical content of this news release.

The Mineral Resources for the River Valley Project disclosed in this news release have been calculated by Mr. Todd McCracken, P.Geo., an employee of WSP and independent of New Age Metals. By virtue of his education and relevant experience, Mr. McCracken is a “Qualified Person” for the purpose of National Instrument 43-101. The Mineral Resource has been classified in accordance with CIM Definition Standards for Mineral Resources and Mineral Reserves, (May 2014). Mr. McCracken, P.Geo., has read and approved the contents of this press release as it pertains to the disclosed Mineral Resource calculation.

On behalf of the Board of Directors

“Harry Barr”

Harry G. Barr

Chairman and CEO

ADDITIONAL INFORMATION

Should you have additional inquiries, please contact Paul Poggione, Corporate Development, Tel: 1-613-659-2773, email: [email protected].

New Age Metals

Ontario Field Office: 59 Burtch’s Lane |1000 Islands, Rockport, ON, K0E 1V0 [email protected]

+1-613-659-2773 www.newagemetals.com

 

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

 

Cautionary Note Regarding Forward Looking Statements: This release contains forward-looking statements that involve risks and uncertainties. These statements may differ materially from actual future events or results and are based on current expectations or beliefs. For this purpose, statements of historical fact may be deemed to be forward-looking statements. In addition, forward-looking statements include statements in which the Company uses words such as “continue”, “efforts”, “expect”, “believe”, “anticipate”, “confident”, “intend”, “strategy”, “plan”, “will”, “estimate”, “calculation”, “project”, “goal”, “target”, “prospects”, “optimistic” or similar expressions. These statements by their nature involve risks and uncertainties, and actual results may differ materially depending on a variety of important factors, including, among others, the Company’s ability and continuation of efforts to timely and completely make available adequate current public information, additional or different regulatory and legal requirements and restrictions that may be imposed, and other factors as may be discussed in the documents filed by the Company on SEDAR (www.sedar.com), including the most recent reports that identify important risk factors that could cause actual results to differ from those contained in the forward-looking statements. The Company does not undertake any obligation to review or confirm analysts’ expectations or estimates/calculations or to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events. Investors should not place undue reliance on forward-looking statements.

Peeks Social $PEEK.ca Completes Personas Acquisition $BCOV $AVID

Posted by AGORACOM-JC at 9:07 AM on Tuesday, May 8th, 2018

Peeks large

  • Acquisition of Personas.com Corporation has been completed pursuant to an amalgamation agreement between Peeks Social, a wholly-owned subsidiary of Peeks Social, Personas, Riavera Corp. and a wholly-owned subsidiary of Riavera

TORONTO, May 08, 2018 — Peeks Social Ltd. (TSXV:PEEK) (OTCQB:PKSLF) (“Peeks Social” or “the Company”) is pleased to report that further to its press release dated February 5, 2018, the acquisition of Personas.com Corporation (“Personas”) has been completed pursuant to an amalgamation agreement between Peeks Social, a wholly-owned subsidiary of Peeks Social (“Peeks Social Subco”), Personas, Riavera Corp. (“Riavera”), and a wholly-owned subsidiary of Riavera (“Riavera Subco”).  Articles of amalgamation to amalgamate Peeks Social Subco, Personas, and Riavera Subco were filed on May 2, 2018, resulting in the creation of a single wholly-owned subsidiary named Peeks Social Technologies Holding Inc. (the “Transaction”).

Shareholders of both Peeks Social and Personas overwhelmingly approved the Transaction as reported on April 19 and May 2, 2018. The closing of the Transaction has resulted in the acquisition of the technology assets of the Peeks Social livestreaming product and in the Company receiving 100% of the gross revenue generated by these assets.  Details of the Transaction can be found in the Company’s Information Circular dated March 19, 2018, as posted under the Company’s profile on SEDAR.

Prior to the Transaction, Personas was a private company controlled by Mr. Mark Itwaru, Chairman & CEO of the Company. Riavera is an existing “Control Person” of the Company within the meaning of the rules and policies of the TSX Venture Exchange, and is a significant shareholder of the Company and a related party to Personas prior to the Transaction. Collectively and immediately prior to the Transaction these parties owned an aggregate of 15,602,388 common shares of the Company, representing 24.0% of the issued and outstanding shares of the Company pre-Transaction (non-diluted).

To effect the Transaction the Company issued 175,150,454 common shares to the shareholders of Personas and Riavera Subco (including 61,340,322 issued to Mr. Mark Itwaru, 55,346,527 issued to Riavera, and 1,245,492 issued to certain directors and officers of the Company) on May 7, 2018, at a negotiated price of $0.7308 per share. The closing price of the Company’s common shares on the TSX Venture Exchange on May 7, 2018, was $0.395. The Company now has 240,126,725 issued and outstanding common shares.

Following the Transaction, Mr. Mark Itwaru and Riavera collectively own an aggregate of 132,289,237 common shares of the Company, representing 55% of the issued and outstanding common shares of the Company (non-diluted). This ownership position, being over 50% of the outstanding voting common shares, provides Mr. Itwaru with the sole ability to determine who is elected as directors of the Corporation. As a majority shareholder, there may be conflicts of interest that arise between Mr. Itwaru and the Corporation.

The Peeks Social app can be downloaded in either the Apple or Google app stores or by visiting www.peeks.social

For further information, please contact:

Peeks Social Ltd.
Mark Itwaru
Chairman & Chief Executive Officer
416-815-7000 x303
[email protected]

David Vinokurov
Director Investor Relations
416-716-9281
[email protected]

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has reviewed or accepts responsibility for the adequacy or accuracy of this Release.

Kuuhubb $KUU.ca Acquires Full Global Rights and Revenue to My Hospital Game $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 9:04 AM on Tuesday, May 8th, 2018

  • Signed the definitive agreement for, and completed the acquisition of, the full global rights and revenue to the My Hospital game
  • Kuuhubb has purchased the full global rights and revenue to the My Hospital game for 2.6 million Euros, to be paid in monthly instalments between May 2019 and June 2021

TORONTO, May 08, 2018 – Kuuhubb Inc. (“Kuuhubb” or the “Company”) (TSX-V:KUU) announces that, further to its February 28, 2018 press release, it has signed the definitive agreement for, and completed the acquisition of, the full global rights and revenue to the My Hospital game.

Kuuhubb has purchased the full global rights and revenue to the My Hospital game for 2.6 million Euros, to be paid in monthly instalments between May 2019 and June 2021.  Additionally, after Kuuhubb has recouped the entire purchase price, Cherrypick Games is entitled to 25% net profit share.  Cherrypick Games will continue the current game development and update efforts until June 2021.

“We are delighted with the long-term potential of My Hospital.  The acquisition of My Hospital from Cherrypick Games is expected to provide Kuuhubb with cash flow and profitability as well as create long-term value through our expanding product portfolio globally,” commented Jouni Keränen, CEO of Kuuhubb.

About Kuuhubb
Kuuhubb is a company active in the digital space that focuses mainly on lifestyle and mobile video game applications. Its strategy is to create sustainable shareholder value through acquisitions of proven, yet underappreciated, assets with robust long-term growth potential. Headquartered in Helsinki, Finland, the Company has a global presence with a strong focus on developing U.S. brand collaborations and Asian partnerships.

Cautionary Note Concerning Forward-Looking Information
This press release contains forward-looking information.  All statements, other than statements of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements relating to the potential of My Hospital, future cash flow and profitability, growth of the Company’s business and expected benefits from the My Hospital acquisition) are forward-looking information. This forward-looking information reflects the current expectations or beliefs of the Company based on information currently available to the Company. Forward-looking information is subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking information, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on the Company.  Factors that could cause actual results or events to differ materially from current expectations include, among other things, risks related to the growth strategy of the Company, the possibility that results from the My Hospital acquisition will not be consistent with the Company’s expectations, the early stage of the Company’s development, competition from companies in a number of industries, the ability of the Company to manage expansion, future business development of the Company and the other risks disclosed under the heading “Risk Factors” in the Company’s annual information form dated October 30, 2017 filed on SEDAR at www.sedar.com.  Forward-looking information speaks only as of the date on which it is provided and, except as may be required by applicable securities laws, the Company disclaims any intent or obligation to update any forward-looking information, whether as a result of new information, future events or results or otherwise.  Although the Company believes that the assumptions inherent in the forward-looking information are reasonable, forward-looking information is not a guarantee of future performance and accordingly undue reliance should not be put on such information due to the inherent uncertainty therein.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

For further information, please contact:

Kuuhubb Inc.
Jouni Keränen – CEO
[email protected]
Office: +358 40 590 0919

Bill Mitoulas
Investor Relations
[email protected]
Office: +1 (416) 479-9547

FEATURE: Tartisan Nickel $TN.ca Kenbridge Property Hosts M&I Resource of 7.14 Million Tonnes at 0.62% Nickel, 0.33% Copper

Posted by AGORACOM-JC at 4:32 PM on Monday, May 7th, 2018

TN:CSE

Investment Highlights

  • Acquisition of Canadian Arrow Mines Limited includes two Ontario-based nickel-copper-(cobalt) properties
  • Canadian Arrow’s Kenbridge property has a measured and indicated resource of 7.14 million tonnes at 0.62% nickel, 0.33% copper
  • 20 percent equity stake in Eloro Resources and 2 percent NSR in their La Victoria property with drill program in progress
  • Strong management team with proven experience in advancing projects to production readiness and increasing shareholder value
  • Tightly held share structure with 50 percent owned by approximately 10 investors

Kenbridge Ni Project (ON, Canada)

  • Advanced  stage  deposit  remains open  in  three  directions,  is  equipped with a 623m  deep  shaft  and  has  never  been  mined.
  • Preliminary  Economic Assessment completed in   2008   and later updated returned robust project
    economics and operating costs including  a  NPV  of  C$253M  and  cash costs of US$3.47/lb of nickel net of
    copper credits.
  • Plans for Kenbridge include updating the 2008 PEA, advancing the project through to feasibility and exploring
    the open mineralization at depth

#Blockchain As An Application Platform $SX $SX.ca $IDK.ca #Blockstation $HIVE.ca $BLOC.ca $CODE.ca

Posted by AGORACOM-JC at 10:30 AM on Monday, May 7th, 2018
  • Many business use cases can be improved and/or solved by using distributed ledger technology
  • Can be used in many cases where trust services are needed by business applications
  • Can be utilized by using blockchain technology as an application platform to build the underlying trust infrastructure of the system

Issam (Sam) Andoni

Seasoned technologist and recognized expert in the field of IDM, Security and Access Management, and the use of PKI technology.

 Issam (Sam) Andoni , Forbes Councils

Shutterstock

Many business use cases can be improved and/or solved by using distributed ledger technology. It can be used in many cases where trust services are needed by business applications. This can be utilized by using blockchain technology as an application platform to build the underlying trust infrastructure of the system.

Although Bitcoin, the first real implementation of blockchain, is a decentralized currency and payment system, the underlying constructs that form the basis of the system do not have to be limited to payment transactions, accounts, balances or users. Instead, blockchain technology in Bitcoin is nothing more than transactions secured and executed by a scripting language using cryptographic methods. This means that blockchain is a platform with a scripting language that can solve many use cases other than just cryptocurrencies.

This property of blockchain led to smart contracts, an innovation presented by the cryptocurrency known as Ethereum. In the case of Ethereum, developers can create private cryptocurrencies and contract-based applications using a Turing-complete language, which allows businesses to use this language to set their own rules and policies in such applications.

The distributed ledger technology used in blockchain offers multiple benefits to businesses that make a difference when implementing a solution that requires a high degree of trust for business transactions. Using the technology offers the possibility to reduce costs and offers the opportunity for businesses to build and maintain an infrastructure that delivers capabilities at lower expenses than traditional centralized models.

Blockchain can process transactions faster because it doesn’t use a centralized infrastructure. Although there is no system totally secure from cyberattacks, the distributed nature of blockchain provides an unprecedented level of trust. The unchangeable property of blockchain and its public availability among its users, whether in a public ledger or a private one, provides transparency. Any user of the system can query transactions on a real-time basis.

Blockchain For Cryptocurrency

Bitcoin was the first implementation of a cryptocurrency based on distributed ledger technology. It was invented in 2009. and since then, it has been gaining popularity and traction by business owners seeking a distributed trust model. The Bitcoin consensus algorithm is based on proof of work (PoW). In PoW, transactions are collected into blocks by miners and added to the blockchain only if the miner can solve a cryptographic challenge that requires much computational power to be solved. The cryptographic challenge can only be solved by guessing, ensuring neutrality.

Other forms of proofs have been invented and incorporated into other solutions, such as the proof of stake in Ethereum and proof of elapsed time introduced by Intel.

Bitcoin and blockchain solved a very old digital currency problem that many other digital currencies tried to solve in the past known as the double spending problem. Double spending means spending the same digital currency twice, and Bitcoin solved this by ensuring distributed consensus.

Another cryptocurrency benefit that blockchain technology provides is that transfers can cross national boundaries in seconds, with minimum fees, and without going through third-party entities such as banks.

Read entire article here: https://www.forbes.com/sites/forbestechcouncil/2018/05/07/blockchain-as-an-application-platform/#e679c405576e

Namaste $N.ca $NXTTF Signs Exclusive Drop-Shipping Agreement With Ample Organics Enabling Ample’s Licensed Producer Customers to Sell Vaporizers and Accessories $ACB.ca $HIP.ca $WEED.ca $CMED.ca

Posted by AGORACOM-JC at 9:49 AM on Monday, May 7th, 2018

  • Signed an exclusive drop-shipping supply agreement with Ample Organics Inc.
  • Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis
  • Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system

VANCOUVER, British Columbia, May 07, 2018 — Namaste Technologies Inc. (“Namaste” or the “Company”) (TSXV:N) (FRA:M5BQ) (OTCMKTS:NXTTF) is pleased to announce that the Company has signed an exclusive drop-shipping supply agreement (the “Agreement”) with Ample Organics Inc. (“Ample Organics”). Ample Organics is Canada’s leading seed-to-sale software platform, currently used by the majority of Canada’s licensed producers of medical cannabis (“LPs”). Under the terms of the Agreement, Namaste will connect its cannabis hardware and accessory platform via API integration with Ample Organics’ system. This will allow each of Ample Organics’ LP customers to have instant access to a large variety of devices and accessories available for purchase during checkout. The Agreement will provide added value for Ample Organics customers by offering their patients industry-leading products. Namaste is proud to have this unique opportunity in partnering with Canada’s most innovative seed-to-sale software company and this Agreement clearly demonstrates Namaste’s continued focus on achieving technological development for the cannabis industry.

Key Terms of the Agreement

  • Namaste will supply Ample Organics customers with access to the Company’s full range of vaporizers and accessories through an API integration, as the exclusive drop-shipping supplier to Ample Organics.
  • Namaste will have first right of refusal to supply new products as requested by Ample Organics, or its customers, for drop-shipping through the API integration.
  • In the event that Namaste decides not to carry a new product or cannot source such product within 30 days, Ample Organics will be granted the right to offer the new product using drop-shipping through a 3rd party supplier.
  • Each order will be submitted electronically via API integration that will also provide live access to tracking information, inventory and shipping data.
  • Namaste will be responsible, at its cost for all product support, returns and warranty claims.
  • Unless Namaste advises otherwise, solely due to pricing restrictions from the product manufacturers, Ample Organics and its customers shall agree to set the prices for the Products at a Minimum Advertised Price (MAP), to be specified by Namaste for each product.

Namaste’s partnership with Ample Organics represents a unique opportunity to provide virtually hundreds of thousands of medical cannabis patients with access to a variety of high-quality vaporizers, which research has shown is a far superior and healthier way to consume medical cannabis. This agreement further demonstrates Namaste’s commitment to the medical cannabis patients of Canada, and in ensuring that they have easy and affordable access to the best cannabis hardware products on the market.

The Agreement represents an important step for Namaste and is accretive in nature, as it will provide immediate, low-overhead revenue for both Namaste and Ample Organics. The Company will now focus its efforts on completing the integration with Ample Organics as soon as possible and will continue to explore further opportunities that have the potential to bring value to Namaste, its partners, and the entire cannabis market.

Management Commentary

John X. Prentice, President and CEO of Ample Organics comments; “This partnership represents a substantial value-add for Ample Organics’ clients and their patient customers. It will simplify inventory management and fulfillment for LPs, while ensuring that medical cannabis patients across the country have access to a substantial catalogue of vaporizers and cannabis accessories at great prices. We are excited to continue the development of our relationship with Namaste and look forward to advancing the industry in new and innovative ways together.”

Sean Dollinger, President and CEO of Namaste comments; “We are very proud to be partnered with Ample Organics on this project. It’s been very rewarding to collaborate with the management team, on what we believe is an important initiative for all those involved, most importantly of which are the medical cannabis patients of Canada. We are incredibly excited to be associated with Ample Organics and to have the opportunity to provide healthier, more affordable options for medical patients to consume cannabis. Our commitment to developing a platform with easily accessible products and services for the cannabis industry is what inspired the opportunity to work with Ample Organics. We’re looking forward to completing the integration and to further enhancing the patient experience.”

About Ample

Ample Organics is Canada’s leading cannabis business solution, adopted by 75% of the nation’s Licensed Producers. To date, the Ample Organics platform has processed more than 880,000 orders and 16,000,000 grams of cannabis. Ample Organics makes compliance easy by tracking individual plants from seed to consumer and reporting every detail of the growth, production, and sales processes. With Ample Organics, data is collected at the most granular levels, offering insights that can drive business decisions and help to protect public safety. Beyond seed to sale, Ample Organics’ extended suite of products creates a complete ecosystem for cannabis businesses. From easy patient registration to cannabis-exclusive payment solutions, Ample Organics continues to evolve and release new products to provide reliable and compliant solutions for the cannabis industry.

About Namaste Technologies Inc.

Namaste Technologies is a global leader in the sale of medical cannabis consumption devices. Namaste has nine offices with multiple distribution centers around the globe and operates over 30 websites under various brands. Namaste has developed innovative technology platforms including NamasteMD.com, Canada’s first ACMPR compliant telemedicine application. The company is focused on patient acquisition through NamasteMD and intends on building Canada’s largest database of medical cannabis patients. The company’s subsidiary, CannMart Inc. is an ACMPR Licensed Producer with a “sales-only” license, whereby the company will offer a large variety of medical cannabis sourced from domestic and international producers. Namaste will continue to develop and acquire innovative technologies which will provide value to the Company and to its shareholders as well as to the broader cannabis market.

On behalf of the Board of Directors,

Sean Dollinger
Chief Executive Officer
Direct: +1 (786) 389 9771
Email: [email protected]

Further information on Namaste and its products can be accessed through the links below:

namastetechnologies.com
namastevapes.ca
everyonedoesit.ca
namastevaporizers.co.uk
everyonedoesit.co.uk
australianvaporizers.com.au

For more information about Ample Organics, please visit ampleorganics.com or contact:
Peter Slater
VP, Corporate Development
Direct: +1 (416) 262-4175
Email: [email protected]

Forward Looking Information

This press release contains forward-looking information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, Namaste assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Although the Company believes that the expectations and assumptions on which the forward-looking statements are based are reasonable, undue reliance should not be placed on the forward-looking statements because the Company can give no assurance that they will prove to be correct. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. These statements speak only as of the date of this press release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com. This press release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward looking statements are made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995. The Canadian Securities Exchange has neither reviewed nor approved the contents of this press release.

FEATURE: Kuuhubb $KUU.ca Mobile Video Gaming And Apps For Women; $US 6.6M Quarterly Revenues, 33M Downloads, 7M Monthly Active Users $TCEHY $ATVI $CYOU

Posted by AGORACOM-JC at 3:21 PM on Friday, May 4th, 2018

Why Kuuhubb?

  • $US 6.6 Million Quarterly Revenues
  • 200 Million Quarterly Sessions
  • 33 Million Downloads
  • 7 Million Monthly Active Users (MAU)
  • Partnerships: Kellogg’s and Samsung
  • Research Reports Target Significantly Higher Prices (Please Refer To Echelon Wealth Partners and Cormark Securities)
  • Aggressive Global Growth Plans Now Underway
  • Japan Already Established. Japan Mobile Revenues
  • Have Surpassed The USA For 3 Consecutive Years
  • India, Korea and China Are Planned For 2018
  • Global Social App Comparables Are Trading At $58/Monthly Active User (MAU) (Excluding Facebook)

Tetra BioPharma $TBP.ca Signs Second Commercialization Deal with Azevedos Industria Farmaceutica, S.A. for the Lead RX product PPP001 $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:24 AM on Friday, May 4th, 2018

Logo tetrabiopharma rgb web

  • Tetra Bio-Pharma Inc. and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution of PPP001 in Portugal
  • Binding term sheet will pave the way towards signing a Definitive Distribution Agreement.
  • Tetra is eligible to receive an upfront payment, milestone payments and will be paid a share of the profits generated by the sales of PPP001 in Portugal.
  • Azevedos will also be responsible for registering the product, as well as all marketing and distribution in Portugal

OTTAWA, May 04, 2018 – Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX-V:TBP) (OTCQB:TBPMF), and Azevedos Indústria Farmacêutica, S.A. announced that they have signed a binding term sheet for the marketing and distribution of PPP001 in Portugal. This binding term sheet will pave the way towards signing a Definitive Distribution Agreement.

Tetra is eligible to receive an upfront payment, milestone payments and will be paid a share of the profits generated by the sales of PPP001 in Portugal. Azevedos will also be responsible for registering the product, as well as all marketing and distribution in Portugal.

“We are honored to partner with Azevedos, a company established in 1775, rich in tradition, and a major player in the Portuguese pharmaceutical market. This Partnership deal provides Tetra with its foray into the European market.” stated Dr. Guy Chamberland M.Sc., Ph.D., Interim CEO and Chief Scientific Officer.

“These partnerships are very important for Azevedos Indústria Farmacêutica and mean that international entities recognize our history, values, work and our technology know-how. Although having a long past, Azevedos is a pharmaceutical company turned to the future and focused on new challenges”, says Thebar Miranda, CEO of Azevedos Indústria Farmaceutica, S.A.

About PPP001 
On April 4, 2018, Tetra officially started the Phase 3 trial for PPP001 indicated for terminal stage cancer patients with a goal to improving the quality of life of these patients as well as minimizing their pain. PPP001 is being developed to be the first smokable cannabis product for advanced cancer pain available under prescription.

About Azevedos Indústria Farmacêutica, S.A
Azevedos Group is a two-century Portuguese pharmaceutical brand, whose wide scope of activity ranges from development to distribution, leading manufacturing and exports to more than 60 regulated countries worldwide. Azevedos owns more than 300 MAs for the most relevant therapeutic areas covering all technology forms manufactured at its state of the art plant holding the most recognized certifications.

About Tetra Bio-Pharma: Tetra Bio-Pharma (TSX-V:TBP) (OTCQB:TBPMF) is a biopharmaceutical leader in cannabinoid-based drug discovery and clinical development. Tetra is focusing on three core business pillars: clinical research, pharmaceutical promotion and retail commercialization of cannabinoid-based products. Tetra Bio-Pharma is currently developing a pipeline of five cannabinoid-based products using different delivery systems such as smokable pellets, oral tablets, eye drops and topical ointments.

More information at: www.tetrabiopharma.com

Source: Tetra Bio-Pharma

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements

Some statements in this release may contain forward-looking information. All statements, other than of historical fact, that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future (including, without limitation, statements regarding potential acquisitions and financings) are forward-looking statements. Forward-looking statements are generally identifiable by use of the words “may”, “will”, “should”, “continue”, “expect”, “anticipate”, “estimate”, “believe”, “intend”, “plan” or “project” or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s ability to control or predict, that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements. Factors that could cause actual results or events to differ materially from current expectations include, among other things, without limitation, the inability of the Company, through its wholly-owned subsidiary, GrowPros MMP Inc., to obtain a license for the production of medical marijuana; failure to obtain sufficient financing to execute the Company’s business plan; competition; regulation and anticipated and unanticipated costs and delays, the success of the Company’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the timing of clinical trials, the timing and outcomes of regulatory or intellectual property decisions and other risks disclosed in the Company’s public disclosure record on file with the relevant securities regulatory authorities. Although the Company has attempted to identify important factors that could cause actual results or events to differ materially from those described in forward-looking statements, there may be other factors that cause results or events not to be as anticipated, estimated or intended. Readers should not place undue reliance on forward-looking statements. While no definitive documentation has yet been signed by the parties and there is no certainty that such documentation will be signed The forward-looking statements included in this news release are made as of the date of this news release and the Company does not undertake an obligation to publicly update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities legislation.

For further information, please contact:
Tetra Bio-Pharma Inc.
Dr Guy Chamberland, interim CEO and CSO
[email protected]
514-220-9225

Robert (Bob) Bechard, MBA, MSc., BA,
Vice-President Finance and Business Development
[email protected]
514-817-2514

For media information, please contact:
Daniel Granger
[email protected]
ACJ Communication
O: 1 514-840-7990 M: 1 514-232-1556

Marijuana Company of America’s $MCOA hempSMART(TM) Brand Engages Kim Castle and Verve Integrative to Manage Television Ad Campaign for Its CBD Product Line $AERO $CBDS $CGRW $APH.ca $GBLX

Posted by AGORACOM-JC at 9:12 AM on Friday, May 4th, 2018

15233 mcoa

  • Wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television ad campaign to promote its hempSMART™ product line.
  • Budget for the DRTV program is approximately $100,000.

Escondido, California–(May 4, 2018) – MARIJUANA COMPANY OF AMERICA INC. (OTC Pink: MCOA) (“MCOA” or the “Company“), an innovative hemp and cannabis corporation, is pleased to announce that its wholly owned subsidiary, H Smart, Inc. has engaged Kim Castle of Verve Integrative to create a market strategy and manage a direct response television (DRTV) ad campaign to promote its hempSMART™ product line.

The Company anticipates that its recently announced EPCO direct sales marketing campaign, in conjunction with the upcoming DRTV marketing campaign and the Company’s ongoing network marketing campaign should result in an improvement in hempSMART™ product sales in Q3 and Q4 2018. The budget for the DRTV program is approximately $100,000.

hempSMART™ is working with Ms. Castle of Verve Integrative and their experienced marketing team to develop a market strategy and a television commercial for the hempSMART™ Pet Drops that will air on cable networks in select regions nationally this summer. The hempSMART™ commercial spot will have featured placement on the official eCommerce site of a well-known DRTV company and will be broadly promoted on integrated social media outlets, benefiting from well-established consumer engagement strategies.

Ms. Castle is leading a team that has more than 25 years of experience in many variations of media strategy, development and production, working for Disney, GM, ABC, Paramount, GreyGroup and McCann, to mention just a few. They specialize in multipoint story experiences designed to educate, entertain and endorse while mirroring the human mind’s process of solving a problem, thereby supporting consumers in making emotional and logical product conclusions. Ms. Castle’s experience both in front of and behind the camera provides an invaluable edge to the hempSMART™ marketing campaign.

In addition, Ms. Castle has personally been an advocate of CBD as an alternative to traditional products currently on the market. “We are very pleased to partner with hempSMART™ on their journey to bring such thoughtful and well-developed products to the people who need natural relief and enhanced health solutions. I wish hempSMART™ Pet Drops were available to support my cherished dog when we were going through a health challenge together,” said Castle.

Donald Steinberg, CEO of MCOA, stated “Kim’s experience gives us an excellent opportunity to greatly expand the marketing strategy for the hempSMART™ brand and product line. We are honored that the hempSMART™ product line will be managed by her and the Verve Integrative team. We look forward to the new television commercial airing this summer.”

About Marijuana Company of America, Inc.

MCOA is a corporation which participates in: (1) product research and development of legal hemp-based consumer products under the brand name “hempSMART™”, that targets general health and well-being; (2) an affiliate marketing program to promote and sell its legal hemp-based consumer products containing CBD; (3) leasing of real property to separate business entities engaged in the growth and sale of cannabis in those states and jurisdictions where cannabis has been legalized and properly regulated for medicinal and recreations use; and, (4) the expansion of its business into ancillary areas of the legalized cannabis and hemp industry, as the legalized markets and opportunities in this segment mature and develop.

About Our hempSMART Products Containing CBD

The United States Food and Drug Administration (FDA) has not recognized CBD as a safe and effective drug for any indication, and disclaims CBD as a dietary supplement. Our products containing CBD derived from industrial hemp are not marketed or sold based upon claims that their use is safe and effective treatment for any medical condition.

Forward Looking Statements

This news release contains “forward-looking statements” which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as “anticipate”, “seek”, intend”, “believe”, “estimate”, “expect”, “project”, “plan”, or similar phrases may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects, the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based products. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-12G, our quarterly reports on Form 10-Q and other periodic reports filed from time-to-time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.

For more information, please visit the Company’s websites at:

MarijuanaCompanyofAmerica.com
hempSMART.com
NetworkNewsWires/MCOA

Corporate Communications Contact:
NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
[email protected]